Skip to content

Neuroimaging of Anesthetic Modulation of Human Consciousness

Neuroimaging of Anesthetic Modulation of Human Consciousness

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03361605
Enrollment
30
Registered
2017-12-05
Start date
2017-04-12
Completion date
2019-07-12
Last updated
2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study's purpose is to see if mental functions take place during different levels of anesthesia, using a commonly used drug (Propofol). fMRI (functional Magnetic Resonance Imaging, or brain imaging) shows areas in the brain involved in thinking at different depths of anesthesia.

Detailed description

Administering anesthetic drugs to suppress consciousness is an imperatively important step in major surgical operations. Yet the neurobiological mechanisms that underlie loss of consciousness under general anesthesia remain elusive. Despite advancements in understanding the molecular, synaptic, and cellular effects of anesthetics, the large-scale, systems-level modulation of neuronal processes that support conscious cognitive functions is incompletely understood. While profound decreases in global and regional brain metabolism, blood flow, and functional connectivity have been reported, these changes often fail to correlate with the loss and return of consciousness. To date, there is no consciousness meter or gold standard to objectively assess and monitor the level of consciousness under general anesthesia. Several studies suggest that residual cognitive functions may not completely vanish under general anesthesia; however, the level and complexity of residual information processing in the anesthetized brain remains unknown. Finally, the neurobiological mechanisms that govern anesthesia induction and emergence appear to be partially different, but the relevance of these differences to the modulation of the state of consciousness is unclear.

Interventions

DRUGPropofol

Propofol administration

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Must have a body mass index (BMI) less than 30. 2. Must be right handed 3. Must be English speaking 4. Must be capable of giving written informed consent. 5. Must have history of playing tennis (or any type of racquet sport) at least 30 times over lifetime.

Exclusion criteria

1. History of obstructive sleep apnea; 2. History of a difficult airway with a previous anesthetic; 3. History of neurological disorders; 4. Hypertension or other cardiovascular abnormalities; 5. Pulmonary hypertension or other pulmonary abnormalities; 6. Gastroesophageal reflux disease (GERD) or heartburn; 7. History of significant head injury with loss of consciousness; 8. Learning disability or other developmental disorder; 9. Allergic reactions to eggs; 10. Pregnant or nursing mothers; 11. Contraindications to neuroimaging methods; 12. Inability or unwilling to fast, or withhold food and liquid intake, for 8 hours prior to your scheduled study visit. 13. Unwilling to abstain from alcohol use for 24 hours prior to your scheduled study visit. 14. History of drug use, or have a positive drug screen. 15. Tattoos on the head or neck region - all other tattoos are subject to determination by investigators. 16. Any impairment, activity or situation that in the judgment of the study coordinator or Principal Investigators would prevent satisfactory completion of the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During SedationBaseline to 90 minutesChange = BOLD Response During Sedation - BOLD Response During Baseline

Secondary

MeasureTime frameDescription
Change From Baseline in Squeeze PressureBaseline to 90 minutesMeasurements of the force of participants' hand squeezing on a rubber ball in response to instructions. Change = Squeeze Pressure During Sedation - Squeeze Pressure During Baseline.

Countries

United States

Participant flow

Participants by arm

ArmCount
Propofol Administration
Propofol: Propofol administration
29
Total29

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAnalyzable data not available3

Baseline characteristics

CharacteristicPropofol Administration
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
29 Participants
BOLD response0.599 percentage of BOLD signal change
STANDARD_DEVIATION 0.244
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
7 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
18 Participants
Sex: Female, Male
Female
15 Participants
Sex: Female, Male
Male
14 Participants
Squeeze pressure13.98 mmHg
STANDARD_DEVIATION 5.27

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 29
other
Total, other adverse events
0 / 29
serious
Total, serious adverse events
0 / 29

Outcome results

Primary

Change From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation

Change = BOLD Response During Sedation - BOLD Response During Baseline

Time frame: Baseline to 90 minutes

Population: Intent to study brain activity change (BOLD response) during propofol administration

ArmMeasureValue (MEAN)Dispersion
Propofol AdministrationChange From Baseline in Blood Oxygen Level Dependent (BOLD) Response to Sensory Stimuli During Sedation-0.349 percentage of BOLD signal changeStandard Deviation 0.223
Comparison: The null hypothesis is no difference in BOLD response between sedated state and baseline.p-value: <0.0001t-test, 2 sided
Secondary

Change From Baseline in Squeeze Pressure

Measurements of the force of participants' hand squeezing on a rubber ball in response to instructions. Change = Squeeze Pressure During Sedation - Squeeze Pressure During Baseline.

Time frame: Baseline to 90 minutes

Population: Intent to study squeeze pressure change during propofol administration

ArmMeasureValue (MEAN)Dispersion
Propofol AdministrationChange From Baseline in Squeeze Pressure-2.16 Millimeter of mercury (mmHg)Standard Deviation 3.09
Comparison: The null hypothesis is no difference in squeeze pressure between sedated state and baseline.p-value: 0.00148t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026